Status:
RECRUITING
Effects of Extracorporeal Shock Wave Therapy and Pulse Electromagnetic Field Therapy on Lymphoedema
Lead Sponsor:
Zheng-Yu Hoe, MD., PhD.
Conditions:
Lymphedema
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Lymphedema occurs not only in patients with breast cancer and gynecological cancers but also in those where lymphatic drainage is obstructed. Accumulation of lymphatic fluid within tissues results in ...
Detailed Description
There is currently no cure for lymphedema. Literature review revealed extracorporeal shock wave therapy (previously applied to soft tissue diseases such as plantar fasciitis, tennis elbow, frozen shou...
Eligibility Criteria
Inclusion
- Participants must be at least 20 years old and have no significant cognitive, language comprehension, or communication issues, be able to understand and follow instructions, and sign the informed consent form.
- Individuals with lymphedema after treatment for breast cancer or gynecologic cancer are eligible (lymphedema is defined as a circumference difference of \>2 cm in the same location on both limbs).
- You must be able to attend follow-up appointments at specific times during the 12 months of the trial, referred by a rehabilitation physician in the outpatient department.
Exclusion
- The affected limb has unhealed open wounds, acute infections, or other conditions unsuitable for contact-based treatment.
- The affected limb has metastatic tumors.
- The affected limb has untreated deep vein thrombosis.
- Severe clotting abnormalities.
Key Trial Info
Start Date :
October 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06041958
Start Date
October 8 2021
End Date
December 31 2025
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan, 81362